AMANDA GIBSON: Open Payments
NPI 1093294282 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 100 payments from 12 companies in 2025. Trend: 2023 $1,836 · 2024 $1,643 · 2025 $2,190
Food & beverage: $2,105Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $683 |
| Janssen Biotech, Inc. | 19 | $403 |
| Madrigal Pharmaceuticals | 7 | $301 |
| Ardelyx, Inc. | 9 | $179 |
| Regeneron Healthcare Solutions, Inc. | 5 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $144 |
| Phathom Pharmaceuticals, Inc. | 5 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
| GENZYME CORPORATION | 3 | $83 |
| PFIZER INC. | 1 | $20 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, LINZESS, IBSRELA, SKYRIZI, ENTYVIO.
Industry payments across IN — which companies pay providers there.
